Axiom Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-86
| Closed | -$6K | – | 128 |
|
|
2022
Q3 | $6K | Buy |
+86
| New | +$6K | 0.01% | 276 |
|
|
2022
Q1 | – | Sell |
-10,729
| Closed | -$668K | – | 99 |
|
|
2021
Q4 | $668K | Sell |
10,729
-9,248
| -46% | -$576K | 0.65% | 37 |
|
|
2021
Q3 | $1.18M | Buy |
+19,977
| New | +$1.18M | 1.19% | 20 |
|
|
2021
Q1 | – | Sell |
-434
| Closed | -$214 | – | 197 |
|
|
2020
Q4 | $214 | Buy |
+434
| New | +$214 | 0.19% | 109 |
|
|
2019
Q4 | – | Sell |
-37,197
| Closed | -$1.89M | – | 148 |
|
|
2019
Q3 | $1.89M | Sell |
37,197
-102,803
| -73% | -$5.21M | 1.44% | 16 |
|
|
2019
Q2 | $6.36M | Sell |
140,000
-518
| -0.4% | -$23.5K | 1.15% | 17 |
|
|
2019
Q1 | $6.73M | Buy |
140,518
+2,001
| +1% | +$95.9K | 1.28% | 14 |
|
|
2018
Q4 | $7.2M | Buy |
+138,517
| New | +$7.2M | 1.52% | 13 |
|